Showing results (211-220 of 228) with videos related to

Sort By:
Pageof 23
Nature Neuroscience|October 19, 2023
Noninvasive theta-burst stimulation of the human striatum enhances striatal activity and motor skill learningMaximilian J Wessel, Elena Beanato, Traian Popa, et al.
Neuroimage|June 6, 2022
Evaluating reproducibility and subject-specificity of microstructure-informed connectivityPhilipp J Koch, Gabriel Girard, Julia Brügger, et al.
Frontiers in Radiology|July 26, 2023
Variability and reproducibility of multi-echo T2 relaxometry: Insights from multi-site, multi-session and multi-subject MRI acquisitionsElda Fischi-Gomez, Gabriel Girard, Philipp J Koch, et al.
JAMA Network Open|July 6, 2026
Multifocal Noninvasive Deep Brain Stimulation to Enhance Cognition in Mild Cognitive Impairment: A Crossover TrialUmberto Nencha, Monika Pupíková, Margaux di Natale, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 24, 2017
Effects of tDCS on motor learning and memory formation: A consensus and critical position paperEthan R Buch, Emiliano Santarnecchi, Andrea Antal, et al.
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
Neurorehabilitation and Neural Repair|November 22, 2025
Brain Oscillatory Modes as a Proxy of Stroke RecoverySylvain Harquel, Andéol Cadic-Melchior, Takuya Morishita, et al.
Stroke|February 27, 2023
Differential Impact of Brain Network Efficiency on Poststroke Motor and Attentional DeficitsGiorgia G Evangelista, Philip Egger, Julia Brügger, et al.
Stroke|April 19, 2024
Stroke Recovery-Related Changes in Cortical Reactivity Based on Modulation of Intracortical InhibitionSylvain Harquel, Andéol Cadic-Melchior, Takuya Morishita, et al.
The Lancet. Infectious Diseases|April 6, 2025
Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trialMitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, et al.
Pageof 23